RecruitingNCT06570213
Cognitive processing therapy with a nerve block or saline for PTSD
About this title
Read the official source — NCT06570213This study evaluates the effectiveness of Stellate Ganglion Block for people with PTSD.
Medication studyAges 18+United States
Understand this study
What is this study about?
This study evaluates the effectiveness of Stellate Ganglion Block for people with PTSD.
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- ChicagoSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 1, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 270
- Sponsor
- Rush University Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT06570213
- Official title
Show the full official title
Evaluating The Efficacy Of Combined Cognitive Processing Therapy and Stellate Ganglion Blocks for PTSD: A Randomized Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Chicago
Interested in joining this study?
Questions about this study
What is this study about?
This study evaluates the effectiveness of Stellate Ganglion Block for people with PTSD.
Who is behind this study?
The study sponsor is Rush University Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Stellate Ganglion Block.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
